MGC Pharmaceuticals has taken the next step towards launching its potentially breakthrough range of cannabis based skincare products next year after Recent microbiology testing in Slovenia showed “no adverse reactions” to MGC cannabis products that treat psoriasis, acne and seborrhoea ailments. The company says it is on track for a full skin care line roll out in 2017.
23/08/2016 - 17:07
Medical Marijuana company achieves milestone on path to full commercialization
By Matt Birney
23/08/2016 - 17:07
Related Data & Insights
-
MGC PharmaceuticalsClosing price for the last 90 trading daysPowered by Morningstar ®
-
Rank Company Revenue 125th MGC Pharmaceuticals $4.2m 132nd Botanix Pharmaceuticals $3.8m 135th HITIQ $3.2m 137th Adisyn $2.9m 138th rent.com.au $2.8m 200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
25 Mar 2024
Javelin to target Goldfields uranium anomaly
01 Mar 2024
Board Moves March 1, 2024
01 Dec 2023
Board Moves December 1, 2023
28 Jul 2023
Board Moves July 28, 2023
30 Jun 2023
MGC Pharma sacks senior staffer
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX